Structural characterization of glycosaminoglycans from zebrafish in different ages.
The zebrafish (Danio rerio) is a popular model organism for the study of developmental biology, disease mechanisms, and drug discovery. Glycosaminoglycans (GAGs), located on animal cell membranes and in the extracellular matrix, are important molecules in cellular communication during development, in normal physiology and pathophysiology. Vertebrates commonly contain a variety of GAGs including chondroitin/dermatan sulfates, heparin/heparan sulfate, hyaluronan and keratan sulfate. Zebrafish might represent an excellent experimental organism to study the biological roles of GAGs. A recent study showing the absence of heparan sulfate in adult zebrafish, suggested a more detailed evaluation of the GAGs present in this important model organism needed to be undertaken. This report aimed at examining the structural alterations of different GAGs at the molecular level at different developmental stages. GAGs were isolated and purified from zebrafish in different stages in development ranging from 0.5 days to adult. The content and disaccharide composition of chondroitin sulfate and heparan sulfate were determined using chemical assays, liquid chromotography and mass spectrometry. The presence of HS in adult fish was also confirmed using (1)H-NMR.
Zhang
Fuming
F
Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.
Zhang
Zhenqing
Z
Thistle
Robert
R
McKeen
Lindsey
L
Hosoyama
Saori
S
Toida
Toshihiko
T
Linhardt
Robert J
RJ
Page-McCaw
Patrick
P
D000818:Animals; D004187:Disaccharides; D004625:Embryo, Nonmammalian / Q000378:metabolism; D006025:Glycosaminoglycans / Q000737:chemistry* / Q000378:metabolism; D013058:Mass Spectrometry; D015027:Zebrafish / Q000196:embryology / Q000378:metabolism*
D004187:Disaccharides; D006025:Glycosaminoglycans
Neuron. 2004 Dec 16;44(6):947-60
15603738
J Chromatogr B Biomed Sci Appl. 1997 Dec 19;704(1-2):19-24
9518150
J Neurosci. 2002 Feb 1;22(3):842-53
11826114
Nat Rev Drug Discov. 2005 Jan;4(1):35-44
15688071
Dev Dyn. 2006 Dec;235(12):3423-31
17075882
J Cell Biol. 2003 Nov 10;163(3):625-35
14610063
Development. 2005 Nov;132(22):4963-73
16221725
J Biol Chem. 2003 Aug 15;278(33):31118-27
12782624
Exp Lung Res. 2007 Dec;33(10):549-54
18075830
Anal Biochem. 2006 Jun 15;353(2):284-6
16529709
Science. 2001 Aug 31;293(5535):1670-3
11533493
Dev Cell. 2001 Aug;1(2):251-64
11702784
Annu Rev Biochem. 2005;74:385-410
15952892
Dev Biol. 2005 Aug 15;284(2):364-76
16009360
Biol Pharm Bull. 2007 Oct;30(10):1819-25
17917244
Glycoconj J. 2007 Dec;24(9):521-30
17541818
Development. 2008 May;135(10):1771-80
18403410
Nat Genet. 1998 Apr;18(4):345-9
9537416
J Biol Chem. 2004 Jan 23;279(4):2608-15
14610083
J Clin Oncol. 2007 Jun 10;25(17):2473-9
17557959
J Pharm Sci. 1992 Aug;81(8):823-7
1328601
Curr Opin Genet Dev. 2000 Jun;10(3):252-6
10826982
Dev Biol. 2000 May 1;221(1):206-19
10772802
Anal Biochem. 1962 Oct;4:330-4
13971270
Int Rev Cytol. 2007;261:159-92
17560282
Curr Opin Drug Discov Devel. 2003 Mar;6(2):218-23
12669457
Dev Dyn. 1998 Nov;213(3):334-47
9825868
Blood. 2004 Mar 1;103(5):1710-9
14592839